- Home
- CERS vs MITT Comparison
CERS vs MITT Comparison
Compare CERS & MITT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERS
- MITT
- Stock Information
- Founded
- CERS 1991
- MITT 2011
- Country
- CERS United States
- MITT United States
- Employees
- CERS N/A
- MITT N/A
- Industry
- CERS EDP Services
- MITT Real Estate Investment Trusts
- Sector
- CERS Technology
- MITT Real Estate
- Exchange
- CERS Nasdaq
- MITT Nasdaq
- Market Cap
- CERS 276.0M
- MITT 230.0M
- IPO Year
- CERS 1997
- MITT 2011
- Fundamental
- Price
- CERS $1.69
- MITT $7.78
- Analyst Decision
- CERS Buy
- MITT Strong Buy
- Analyst Count
- CERS 1
- MITT 5
- Target Price
- CERS $4.00
- MITT $8.60
- AVG Volume (30 Days)
- CERS 1.3M
- MITT 173.1K
- Earning Date
- CERS 11-06-2025
- MITT 11-04-2025
- Dividend Yield
- CERS N/A
- MITT 10.66%
- EPS Growth
- CERS N/A
- MITT N/A
- EPS
- CERS N/A
- MITT 0.94
- Revenue
- CERS $199,191,000.00
- MITT $87,678,000.00
- Revenue This Year
- CERS $19.07
- MITT N/A
- Revenue Next Year
- CERS $12.03
- MITT $14.27
- P/E Ratio
- CERS N/A
- MITT $8.39
- Revenue Growth
- CERS 13.03
- MITT 8.59
- 52 Week Low
- CERS $1.12
- MITT $5.63
- 52 Week High
- CERS $2.24
- MITT $7.97
- Technical
- Relative Strength Index (RSI)
- CERS 59.26
- MITT 59.21
- Support Level
- CERS $1.47
- MITT $7.64
- Resistance Level
- CERS $1.78
- MITT $7.87
- Average True Range (ATR)
- CERS 0.13
- MITT 0.14
- MACD
- CERS 0.01
- MITT 0.01
- Stochastic Oscillator
- CERS 78.75
- MITT 62.82
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
About MITT AG Mortgage Investment Trust Inc.
AG Mortgage Investment Trust Inc is a real estate investment trust (REIT). It focuses on investing in a diversified risk-adjusted portfolio of residential mortgage-related assets in the U.S. mortgage market. Its objective is to provide attractive risk-adjusted returns to its stockholders over the long term through dividends and capital appreciation. It also focuses on investing in residential mortgage-backed securities (RMBS) issued or guaranteed by a government-sponsored enterprise.